Follow us on
Search News Archives
Conferences | Events
Lab Bulletin Media Partners
Becton Dickinson and Company

Becton Dickinson and Company

Becton Dickinson and Company

Products

Contact Becton Dickinson and Company


If you have not logged into the website then please enter your details below.

All articles from Becton Dickinson and Company

  New Diagnostic Test Helps Hospitals More Quickly Identify and Treat Emerging Antibiotic-Resistant Bacteria

BDBD, a leading global medical technology company, has announced the U.S. Food and Drug Administration 510(k) clearance of the BD Phoenix™ CPO detect test, which will allow hospitals to identify infections caused by carbapenemase-producing organisms (CPOs). The test may help hospitals contain the spread of antimicrobial resistance (AMR) by shortening the time it takes to detect CPOs, thereby enabling the earlier implementation of infection control procedures and...

 

  New Case Study | Improving Lab Performance through Informatics

By Rajeev Sehgal, Director of Informatics at BD (Becton, Dickinson and Company)

Microbiology laboratories are facing challenges on a number of fronts: cost pressures and staff shortages constrain their ability to process samples, and increasing test volumes make it difficult for some labs to run tests and get results back to clinicians in a timely manner. Microbiology labs are constantly juggling at least four key priorities....

 

  BD Unveils Suite of Diagnostic Informatics and Automation Innovations

BD (Becton, Dickinson and Company), a leading global medical technology company, has introduced several new informatics and automation solutions for clinical laboratories, which may play a critical role in the fight against infectious diseases and antimicrobial resistance....

 

  BD Launches Circulating Cell-Free DNA Blood Collection Tube for Cancer and Non-Invasive Prenatal Testing Applications

preanalytixCE-IVD labeled PAXgene® Blood ccfDNA tube will be available in Western Europe. BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the commercial availability of the CE-IVD marked PAXgene® Blood ccfDNA tube within the European Economic Area and Switzerland (Western Europe). The plastic blood collection tube, which includes a proprietary...

 

  BD Receives CE Mark for Next Generation Blood Separation Technology

BD Vacutainer® Barricor™ Tube Designed to Enhance Sample Quality, Improve Laboratory Efficiency and Speed Laboratory Turnaround Time

BDBD (Becton, Dickinson and Company), a leading global medical technology company, announced today that it obtained the CE mark in the UK and Europe for a next-generation blood separation technology that is designed to enhance sample quality, improve laboratory efficiency and reduce laboratory turnaround time. BD Vacutainer® Barricor™ tube is a single-use, plastic evacuated tube used to collect...

 

  Fluidigm & BD Biosciences to Co-Host Single-Cell Seminars FluidigmFluidigm Corporation has announced a collaboration with BD Biosciences, a segment of BD (Becton, Dickinson and Company), to co-host a public seminar series on the isolation and analysis of single cells. Entitled 'A Powerful Technique for Single-Cell Analysis', the public seminar series will showcase cell isolation using the BD FACSAria III Cell Sorter and analysis using the Fluidigm BioMark HD System...